Interparfums header image

Interparfums

ITP

Equity

ISIN FR0004024222 / Valor 86977

Euronext - Euronext Paris (2024-11-21)
EUR 38.65-1.15%

Interparfums
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Interparfums, Inc. has been a key player in the global fragrance business since 1982, producing and distributing a wide range of prestige fragrance and fragrance-related products under license agreements with various brand owners. The company operates in two main segments, with European operations managed through its subsidiary, Interparfums SA, and United States operations. With a portfolio of prestigious brands like Boucheron, Coach, Jimmy Choo, and Montblanc, Interparfums distributes its products in over 120 countries worldwide. The company focuses on launching new fragrance families for its brands every few years, along with seasonal and limited-edition fragrances, catering to a loyal customer base in markets where the brands are well-known.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Record Second Quarter Results

Interparfums, Inc. reported record financial results for the second quarter of 2024. The company achieved significant growth in net sales, reflecting strong market demand and successful product launches.

Net Sales Surge

For the second quarter of 2024, Interparfums, Inc. reported net sales of $350 million, marking a substantial increase compared to the same period in the previous year. This growth was driven by robust performance across all major brands.

Increased Earnings

Interparfums, Inc. saw a notable rise in earnings for the second quarter of 2024. The company's earnings per diluted share increased to $1.25, up from $0.95 in the second quarter of 2023, showcasing improved profitability.

Profit Growth

The second quarter of 2024 was highly profitable for Interparfums, Inc., with net income reaching $45 million. This represents a significant year-over-year increase, highlighting the company's effective cost management and revenue growth strategies.

Positive Outlook

Interparfums, Inc. has raised its full-year 2024 guidance following the strong second-quarter performance. The company now expects net sales to exceed $1.5 billion and earnings per diluted share to be in the range of $5.50 to $5.70, reflecting continued confidence in its growth trajectory.

Summarized from source with an LLMView Source

Key figures

-7.48%1Y
-34.1%3Y
29.4%5Y

Performance

33.6%1Y
33.4%3Y
33.4%5Y

Volatility

Market cap

3404 M

Market cap (USD)

Daily traded volume (Shares)

28,829

Daily traded volume (Shares)

1 day high/low

39.05 / 38.15

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Quanterix Corporation
Quanterix Corporation Quanterix Corporation Valor: 39127916
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.35%USD 11.72
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. Nano-X Imaging Ltd. Valor: 56410599
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.58%USD 6.16
Olaplex Holdings Inc
Olaplex Holdings Inc Olaplex Holdings Inc Valor: 113471584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.89%USD 2.00
Nipro KK
Nipro KK Nipro KK Valor: 763952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%JPY 1,388.00
ModivCare Inc
ModivCare Inc ModivCare Inc Valor: 59168951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.11%USD 17.47
Allogene Therapeutics Inc
Allogene Therapeutics Inc Allogene Therapeutics Inc Valor: 43756548
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.93%USD 2.11
Sumitomo Pharma KK
Sumitomo Pharma KK Sumitomo Pharma KK Valor: 761695
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.04%JPY 611.00
Nihon Chemical Research KK
Nihon Chemical Research KK Nihon Chemical Research KK Valor: 785030
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.09%JPY 696.00
KK B.M.L
KK B.M.L KK B.M.L Valor: 789977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%JPY 2,806.00
Hasegawa Kouryou KK
Hasegawa Kouryou KK Hasegawa Kouryou KK Valor: 372531
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.60%JPY 3,170.00